BDR OFFERING
June 06 2008 - 2:01AM
UK Regulatory
RNS Number : 1220W
Infinity Bio-Energy Ltd
06 June 2008
Infinity Bio-Energy Ltd.
("Infinity" or the "Company")
Infinity Bio-Energy files with CVM for BDR offering and BOVESPA listing and calls Shareholders' Meeting to approve new by-laws
conforming to Novo Mercado standards
Infinity Bio-Energy Ltd. (AIM: IBI.L) announced today that it has filed an application with the Brazilian Securities Commission (CVM) to
register the Company as a foreign issuer in Brazil and to issue Brazilian Depositary Receipts ("BDRs") in a public offering in Brazil and
with international placement efforts. As described in the application to register with the CVM, the BDR program will contemplate the
issuance of new common shares to finance the continuing growth of the Company, through new acquisitions, financing of Greenfield projects,
industrial investments in existing mills and financing of co-generation projects. The BDRs will represent AIM-listed common shares, through
the establishment of a depositary program. The BDRs will be traded on BOVESPA. International placement of BDRs will be made to qualified
investors under Rule 144A in US and to non-US, Brazilians and Bermudian Investors under Regulation S of the Securities Act of 1933. Sales in
UK can be made only to qualified investors, as defined in the Prospectus Directive.
This announcement is not an offer of securities for sale into the United States or in any jurisdiction in which such an offer or
solicitation is unlawful. The securities referenced herein have not been and will not be registered under the US Securities Act of 1933 (the
"Securities Act") or under any relevant securities laws of any state or other jurisdiction of the United States and may not be offered,
directly or indirectly, in the United States absent registration or an applicable exemption from the registration requirements of the
Securities Act and in compliance with state securities laws, or in any other jurisdiction where such offer or sale is prohibited. The
Company does not intend to register any portion of such offering in the United States or to conduct a public offering of its securities in
the United Sates. Prospective purchasers are hereby notified that sellers of the shares may be relying on the exemption from the
registration provisions of Section 5 of the Securities Act provided by Rule 144A under the Securities Act.
On June 2, 2008, the Board of Directors of the Company approved certain amendments to the Company's Bye-laws to conform them to the
corporate governance standards of the Novo Mercado segment of BOVESPA, and the Company has submitted the bye-laws amendments for approval by
the Shareholders in a General Meeting scheduled for June 25, 2008.
For further information, please contact:
Infinity Bio-Energy
Sergio Thompson-Flores, CEO +55 11 3525-9921
Rodrigo Aguiar, IRO +55 11 3525-9922
Collins Stewart Europe Limited
Adrian Hadden/Adam Cowen +44 (0) 20 7523 8350
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUVSRRWVRNRUR
Infinity Bio-energy (LSE:IBI)
Historical Stock Chart
From Apr 2024 to May 2024
Infinity Bio-energy (LSE:IBI)
Historical Stock Chart
From May 2023 to May 2024